NCT05666830

Brief Summary

The goal of this observational study is to study the effectiveness of one-step application of Lando® artificial dermal regeneration matrix for burn and plastic wound repair. The main question it aims to answer is: the effectiveness of one-step application of Lando® artificial dermal regeneration matrix, including the take rate of skin graft and the appearance recovery of the wound. Participants will be treated with artificial dermis that perfomed with STSG simultaneously. According to the routine clinical practice, the take rate of split-thickness skin graft at about 2-3 weeks and the appearance recovery of the wound at 3 months and 6 months after the implantation were measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 28, 2022

Completed
Last Updated

December 28, 2022

Status Verified

December 1, 2022

Enrollment Period

1.7 years

First QC Date

December 19, 2022

Last Update Submit

December 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Take rate of skin graft

    The percentage of the area of survival skin graft assessed by the Investigator.

    2~3 weeks

Secondary Outcomes (7)

  • Effective rate of skin grafting

    2~3 weeks

  • Vancouver Scar Scale score of skin grafting site

    3 months

  • Vancouver Scar Scale score of skin grafting site

    6 months

  • Vancouver Scar Scale score of donor site

    3 months

  • Vancouver Scar Scale score of donor site

    6 months

  • +2 more secondary outcomes

Study Arms (1)

1

Participants will be treated with artificial dermis that perfomed with STSG simultaneously.

Device: Lando® artificial dermal regeneration matrix

Interventions

Participants will be treated with artificial dermis that perfomed with STSG simultaneously.

1

Eligibility Criteria

AgeUp to 70 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with non-infectious wounds of deep burns, full-thickness traumatic skin defects or plastic surgery that require repair and reconstruction of dermal defects.

You may qualify if:

  • Age ≤ 70 years old.
  • Patients with non-infectious wounds of deep burns, full-thickness traumatic skin defects or plastic surgery that need to be repaired and reconstructed by artificial dermis.
  • Patients who voluntarily participate in this clinical trial and sign the informed consent form. When the subjects are under 18 years old or they have no capacity or limited capacity, they should have the consent and signature of the guardian or legal representative.

You may not qualify if:

  • Patients who need to participate in other clinical researchers within 30 days before or during the period of joining the group.
  • Patients with poor control of diabetes (those with fasting blood glucose ≥ 7.0mmol/L or glycosylated hemoglobin HbA1c ≥ 12% after drug control, transaminase \> 1.5 times and other diabetic complications).
  • Other cases that researchers believe not suitable for the participants of the trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanfang Hospital of Southern Medical University

Guangzhou, Guangdong, 510515, China

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2022

First Posted

December 28, 2022

Study Start

January 28, 2021

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

December 28, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

We are sorry to declaim that the individual participant data is in a state of confidentiality.

Locations